Novavax Inc (NASDAQ:NVAX)
| 16.52 Delayed Data As of Dec 02 |  -0.33 / -1.96%Today’s Change | 15.53 Today|||52-Week Range 236.50 | -88.45% Year-to-Date |
Latest NVAX News | Press Releases
| Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL Nov 30 / Zacks.com - Paid Partner Content | Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know Nov 25 / Zacks.com - Paid Partner Content |
| Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Nov 30 / Zacks.com - Paid Partner Content | Novavax Stock: Buy, Sell, or Hold in 2023? Nov 24 / MotleyFool.com - Paid Partner Content |
| Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why Nov 28 / Zacks.com - Paid Partner Content | Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI Nov 23 / Zacks.com - Paid Partner Content |
| Is Novavax Stock a Buy Now? Nov 26 / MotleyFool.com - Paid Partner Content | Why Shares of Novavax Are Down Tuesday Nov 22 / MotleyFool.com - Paid Partner Content |
| 3 Potentially Explosive Stocks to Buy Before 2023 Nov 26 / MotleyFool.com - Paid Partner Content | Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025 Nov 22 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 16.85 |
| Today’s open | 16.50 |
| Day’s range | 15.54 - 16.52 |
| Volume | 174,799 |
| Average volume (3 months) | 5,138,128 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -222.51% |
| Earnings growth (this year) | +69.97% |
| Earnings growth (next 5 years) | +58.18% |
| Revenue growth (last year) | +141.02% |
| P/E ratio | NM |
| Price/Sales | 9.29 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TVTXTravere Therapeutics... | +0.52 | +2.66% |
| ---- | ||
| ALLOAllogene Therapeutic... | +0.09 | +0.91% |
| QUREUniqure NV | -0.26 | -0.99% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | February 27, 2023 |
| EPS forecast (this quarter) | -$1.10 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$1.7B |
| Net profit margin | -152.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
